 |
|
|
| |
ART in HIV persons with pre-treatment viremia <3000c/mL: the START study
|
| |
| |
Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle WA
Irini Sereti1, Roy M. Gullck2, Sonya Krishnan1*, Stephen A. Migueles1, Adrian Palfreeman3, Veronique Touzeau-Romer4, Waldo Belloso5, Sean Emery6 and Matthew Law6 for the INSIGHT Network
1National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA, 2Weill Cornell Medicine, New York, NY, USA, 3Leicester Royal Infirmary, Leicester, UK 4Medical University of Vienna, Vienna, Austria, 5Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 6The Kirby Institute, UNSW, Sydney, Australia"
*Current affiliation: Johns Hopkins University, Baltimore, MD, USA
|
| |
|
|
|
|
|
